People: Canadian Neurosurgeon Assumes Helm Of Animal Welfare Monitoring Group

Donald Boisvert, a research professor in the department of surgery at the University of Alberta in Edmonton, has left his research post in Alberta to become executive director of the Canadian Council on Animal Care (CCAC), based in Ottawa. He began in the position August 4. CCAC is a peer-review organization that monitors the scientists who use animals for research, education, and testing. There are roughly 2 million animals in Canadian labs, and Boisvert says he hopes to make CCAC more accessi

Written byRon Kaufman
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

Donald Boisvert, a research professor in the department of surgery at the University of Alberta in Edmonton, has left his research post in Alberta to become executive director of the Canadian Council on Animal Care (CCAC), based in Ottawa. He began in the position August 4. CCAC is a peer-review organization that monitors the scientists who use animals for research, education, and testing. There are roughly 2 million animals in Canadian labs, and Boisvert says he hopes to make CCAC more accessible to researchers with questions about animal treatment. The organization was formed in 1968 by a group of scientists in order to, in the words of its mandate, “work for the improvement of animal care and use on a Canada-wide basis.” For the past 10 years, Boisvert has been involved in the care and treatment of laboratory animals. “I neither oppose nor promote experimental animal use,” says Boisvert, who ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies